← SynDRA
LORECIVIVINT
SynDRA canonical compound SYN0039729 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Mechanism of action | WNT pathway inhibitor |
All known targets
Mechanisms of action (all sources)
- DYRK1A INHIBITOR
- Dual specificity tyrosine-phosphorylation-regulated kinase 1A inhibitor
- CLK2 INHIBITOR
- Dual specificity protein kinase CLK2 inhibitor
- Wnt pathway inhibitor
Drug classes
Cross-references
Synonyms
- Adavivint
- SM04690
- SM-04690
- lorecivivintum
- RefChem:924928
- Lorecivivint [USAN]
- Adavivint (SM04690)
- MFCD30489411
- Adavivint?
- Adavivint [INN]
- Lorecivivint [WHO-DD]
- Adavivint; SM04690
- Lorecivivint (USAN/INN)
- LORECIVIVINT [INN]
- adavivint (deprecated INN)
- UNII-42EK42WHI5
- C29H24FN7O
- GTPL9620
- orb1301632
- SCHEMBL15302155
- SCHEMBL23777531
- SCHEMBL29369534
- SCHEMBL29383887
- SCHEMBL30934911
- GLXC-21174
- EX-A2711
- SIC09303
- BDBM50589392
- s8761
- WHO 10389
- AKOS040758781
- EBC-609294
- NCGC00601804-01
- AC-31570
- AS-84223
- SM0-4690
- DB-188479
- HY-109049
- CS-0031495
Look up LORECIVIVINT in the interactive SynDRA portal →